Med.ish Laser Spa and WeightLoss:Charlotte's #1- WeightLoss Laser Hair Removal Semaglutide Tirzepatide Liquid Lipo has source-ready treatment evidence for Tirzepatide evidence. Confirm current medication availability, pharmacy model, and pricing before booking.
Med.ish Laser Spa and WeightLoss:Charlotte's #1- WeightLoss Laser Hair Removal Semaglutide Tirzepatide Liquid Lipo
Type
Medical Clinic
Location
Charlotte, North Carolina
Starting At
$500+
Rating
5/5 (123 reviews)
About This Provider
Med.ish Laser Spa and WeightLoss:Charlotte's #1- WeightLoss Laser Hair Removal Semaglutide Tirzepatide Liquid Lipo is a medical clinic listed in the GLP1Search directory serving patients in Charlotte, NC. Public listing data includes source-ready evidence for Tirzepatide evidence; confirm current treatment availability directly with the provider.
Visit their website at medishspa.com for the most current information on pricing, medications, and availability.
Google Reviews
Based on 123 Google reviews
Rating Distribution (estimated)
123 total reviews
Business Details
Accessibility
Payment Methods
Community
What Patients Should Know
Before You Start
Confirm total monthly costs upfront — including membership fees, medication costs, and consultation charges. Ask about insurance coverage.
Medication Options
GLP-1 medications include Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound). Ask which options are available and their sourcing.
Clinical Oversight
Verify your assigned clinician's credentials. Ensure regular check-ins and dose adjustments are part of the program.
Our Independence
GLP1Search does not accept referral fees. All provider data is collected independently from public sources.
Get weekly GLP-1 pricing updates
Provider comparisons, new clinic alerts, and research — delivered to your inbox.
No spam. Unsubscribe anytime.
Not sure which provider is right for you?
Every body is different. Compare pricing, medication options, pharmacy standards, and patient experiences across all 18,771 public provider records, with treatment-evidence and directory-only labels kept separate.